HK Stock MarketDetailed Quotes

CENTRAL NEW EGY (01735)

Watchlist
  • 9.810
  • +0.140+1.45%
Market Closed May 22 16:05 CST
41.44BMarket Cap1226.25P/E (TTM)

CENTRAL NEW EGY (01735) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
46.21%82.29M
----
-32.07%56.28M
----
367.18%82.85M
----
-138.99%-31.01M
----
1,951.56%79.54M
----
Profit adjustment
Interest (income) - adjustment
-82.27%-17.98M
----
-614.27%-9.86M
----
-482.70%-1.38M
----
-35.43%-237K
----
-2.94%-175K
----
Attributable subsidiary (profit) loss
---80K
----
----
----
----
----
----
----
----
----
Impairment and provisions:
----
----
84.17%-3.7M
----
-166.19%-23.4M
----
1,413.48%35.36M
----
60.88%2.34M
----
-Impairment of trade receivables (reversal)
----
----
84.51%-3.7M
----
-167.12%-23.91M
----
1,606.23%35.63M
----
175.10%2.09M
----
-Other impairments and provisions
----
----
----
----
288.56%511K
----
-209.27%-271K
----
-64.21%248K
----
Revaluation surplus:
-85.98%1.41M
----
290.79%10.05M
----
-132.11%-5.27M
----
136.25%16.41M
----
-26.75%-45.25M
----
-Fair value of investment properties (increase)
----
----
293.71%10.04M
----
-170.95%-5.19M
----
116.15%7.31M
----
-26.75%-45.25M
----
-Derivative financial instruments fair value (increase)
--1.73M
----
----
----
----
----
----
----
----
----
-Other fair value changes
-6,480.00%-319K
----
106.10%5K
----
-100.90%-82K
----
--9.1M
----
----
----
Asset sale loss (gain):
19.38%-41.92M
----
-293.35%-51.99M
----
62.19%-13.22M
----
-4,155.57%-34.96M
----
--862K
----
-Loss (gain) from sale of subsidiary company
62.44%-19.87M
----
-356.79%-52.9M
----
66.87%-11.58M
----
-3,950.11%-34.96M
----
--908K
----
-Loss (gain) on sale of property, machinery and equipment
-2,528.19%-22.05M
----
--908K
----
----
----
----
----
---46K
----
-Loss (gain) from selling other assets
----
----
----
----
---1.64M
----
----
----
----
----
Depreciation and amortization:
34.30%190.81M
----
659.95%142.08M
----
100.86%18.7M
----
-1.21%9.31M
----
171.29%9.42M
----
Financial expense
29.54%66.56M
----
103.99%51.39M
----
356.34%25.19M
----
61.73%5.52M
----
4,390.79%3.41M
----
Special items
----
----
---148K
----
----
----
---9.17M
----
----
----
Operating profit before the change of operating capital
44.83%281.1M
----
132.52%194.09M
----
1,049.51%83.47M
----
-117.53%-8.79M
----
285.09%50.14M
----
Change of operating capital
Inventory (increase) decrease
-147.77%-22.12M
----
126.34%46.29M
----
-367.98%-175.74M
----
---37.55M
----
----
----
Accounts receivable (increase)decrease
-332.35%-1.21B
----
77.09%-280.83M
----
-546.20%-1.23B
----
-60.96%-189.66M
----
-1,145.17%-117.83M
----
Accounts payable increase (decrease)
649.38%865.63M
----
-83.71%115.51M
----
721.59%709.03M
----
-15.10%86.3M
----
-22.62%101.65M
----
Special items for working capital changes
188.57%391.66M
----
-12.96%-442.23M
----
-550.01%-391.49M
----
241.94%87M
----
-62.40%-61.29M
----
Cash  from business operations
182.28%302.11M
----
63.29%-367.17M
----
-1,495.20%-1B
----
-129.43%-62.71M
----
-156.92%-27.33M
----
Other taxs
42.24%-17.34M
----
-1,966.35%-30.02M
----
71.17%-1.45M
----
-682.61%-5.04M
----
-388.79%-644K
----
Special items of business
----
-66.35%175.49M
----
185.55%521.5M
----
-690.78%-609.58M
----
430.97%103.18M
----
-416.75%-31.18M
Net cash from operations
171.70%284.77M
-66.35%175.49M
60.35%-397.19M
185.55%521.5M
-1,378.67%-1B
-690.78%-609.58M
-142.17%-67.75M
430.97%103.18M
-157.99%-27.98M
-416.75%-31.18M
Cash flow from investment activities
Interest received - investment
82.27%17.98M
----
614.27%9.86M
----
774.05%1.38M
----
62.89%158K
----
-10.19%97K
----
Sale of fixed assets
646.83%141.93M
----
--19M
----
----
----
----
----
--2.14M
----
Purchase of fixed assets
51.13%-339.6M
----
9.39%-694.88M
----
-877.66%-766.93M
----
-404.15%-78.45M
----
-19.66%-15.56M
----
Sale of subsidiaries
-109.84%-1.9M
----
118.70%19.35M
----
-72.99%8.85M
----
6,154.53%32.76M
----
---541K
----
Recovery of cash from investments
----
----
----
----
--8.7M
----
----
----
----
----
Cash on investment
---5.27M
----
----
----
---7K
----
----
----
-105.02%-123.08M
----
Other items in the investment business
----
153.89%337.37M
---530K
-261.65%-625.98M
----
-36,187.63%-173.09M
----
96.53%-477K
----
58.32%-13.76M
Net cash from investment operations
71.13%-186.86M
153.89%337.37M
13.48%-647.2M
-261.65%-625.98M
-1,542.82%-748.01M
-36,187.63%-173.09M
66.75%-45.53M
96.53%-477K
-70.68%-136.95M
58.32%-13.76M
Net cash before financing
109.37%97.9M
590.85%512.86M
40.31%-1.04B
86.65%-104.48M
-1,444.65%-1.75B
-862.06%-782.67M
31.31%-113.28M
328.58%102.7M
-415.45%-164.92M
-93.97%-44.93M
Cash flow from financing activities
New borrowing
30.28%3.7B
----
147.75%2.84B
----
24.38%1.15B
----
529.82%922.01M
----
--146.39M
----
Refund
-111.25%-3.45B
----
-727.02%-1.63B
----
7.10%-197.52M
----
-423.23%-212.6M
----
---40.63M
----
Interest paid - financing
-29.54%-66.56M
----
-103.99%-51.39M
----
-356.75%-25.19M
----
-61.59%-5.52M
----
-4,390.79%-3.41M
----
Absorb investment income
91.13%61.93M
----
--32.4M
----
----
----
----
----
--1.26M
----
Other items of the financing business
--4K
-219.50%-658.81M
----
-6.64%551.29M
--385M
668.33%590.51M
----
-404.28%-103.9M
289.94%57.81M
234.65%34.15M
Net cash from financing operations
-104.02%-47.69M
-219.50%-658.81M
-9.24%1.19B
-6.64%551.29M
86.30%1.31B
668.33%590.51M
338.66%701.95M
-404.28%-103.9M
615.83%160.02M
234.65%34.15M
Effect of rate
158.08%8.11M
154.36%9.06M
59.64%-13.97M
58.03%-16.66M
-38.16%-34.6M
-1,048.41%-39.69M
-1,749.87%-25.05M
751.87%4.19M
-34.37%1.52M
-688.99%-642K
Net Cash
-64.75%50.22M
-132.66%-145.94M
132.23%142.48M
332.53%446.81M
-175.09%-442.02M
-15,912.75%-192.15M
12,108.73%588.67M
88.87%-1.2M
92.22%-4.9M
77.78%-10.78M
Begining period cash
93.55%265.89M
-50.99%265.89M
-77.63%137.37M
-11.64%542.53M
1,118.90%614M
1,118.90%614M
-6.29%50.37M
-6.29%50.37M
-53.04%53.76M
-53.04%53.76M
Cash at the end
21.94%324.22M
-86.74%129M
93.55%265.89M
154.53%972.68M
-77.63%137.37M
616.20%382.15M
1,118.90%614M
26.05%53.36M
-6.29%50.37M
-35.91%42.33M
Cash balance analysis
Cash and bank balance
----
----
----
----
----
----
----
----
----
-35.91%42.33M
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax 46.21%82.29M-----32.07%56.28M----367.18%82.85M-----138.99%-31.01M----1,951.56%79.54M----
Profit adjustment
Interest (income) - adjustment -82.27%-17.98M-----614.27%-9.86M-----482.70%-1.38M-----35.43%-237K-----2.94%-175K----
Attributable subsidiary (profit) loss ---80K------------------------------------
Impairment and provisions: --------84.17%-3.7M-----166.19%-23.4M----1,413.48%35.36M----60.88%2.34M----
-Impairment of trade receivables (reversal) --------84.51%-3.7M-----167.12%-23.91M----1,606.23%35.63M----175.10%2.09M----
-Other impairments and provisions ----------------288.56%511K-----209.27%-271K-----64.21%248K----
Revaluation surplus: -85.98%1.41M----290.79%10.05M-----132.11%-5.27M----136.25%16.41M-----26.75%-45.25M----
-Fair value of investment properties (increase) --------293.71%10.04M-----170.95%-5.19M----116.15%7.31M-----26.75%-45.25M----
-Derivative financial instruments fair value (increase) --1.73M------------------------------------
-Other fair value changes -6,480.00%-319K----106.10%5K-----100.90%-82K------9.1M------------
Asset sale loss (gain): 19.38%-41.92M-----293.35%-51.99M----62.19%-13.22M-----4,155.57%-34.96M------862K----
-Loss (gain) from sale of subsidiary company 62.44%-19.87M-----356.79%-52.9M----66.87%-11.58M-----3,950.11%-34.96M------908K----
-Loss (gain) on sale of property, machinery and equipment -2,528.19%-22.05M------908K-----------------------46K----
-Loss (gain) from selling other assets -------------------1.64M--------------------
Depreciation and amortization: 34.30%190.81M----659.95%142.08M----100.86%18.7M-----1.21%9.31M----171.29%9.42M----
Financial expense 29.54%66.56M----103.99%51.39M----356.34%25.19M----61.73%5.52M----4,390.79%3.41M----
Special items -----------148K---------------9.17M------------
Operating profit before the change of operating capital 44.83%281.1M----132.52%194.09M----1,049.51%83.47M-----117.53%-8.79M----285.09%50.14M----
Change of operating capital
Inventory (increase) decrease -147.77%-22.12M----126.34%46.29M-----367.98%-175.74M-------37.55M------------
Accounts receivable (increase)decrease -332.35%-1.21B----77.09%-280.83M-----546.20%-1.23B-----60.96%-189.66M-----1,145.17%-117.83M----
Accounts payable increase (decrease) 649.38%865.63M-----83.71%115.51M----721.59%709.03M-----15.10%86.3M-----22.62%101.65M----
Special items for working capital changes 188.57%391.66M-----12.96%-442.23M-----550.01%-391.49M----241.94%87M-----62.40%-61.29M----
Cash  from business operations 182.28%302.11M----63.29%-367.17M-----1,495.20%-1B-----129.43%-62.71M-----156.92%-27.33M----
Other taxs 42.24%-17.34M-----1,966.35%-30.02M----71.17%-1.45M-----682.61%-5.04M-----388.79%-644K----
Special items of business -----66.35%175.49M----185.55%521.5M-----690.78%-609.58M----430.97%103.18M-----416.75%-31.18M
Net cash from operations 171.70%284.77M-66.35%175.49M60.35%-397.19M185.55%521.5M-1,378.67%-1B-690.78%-609.58M-142.17%-67.75M430.97%103.18M-157.99%-27.98M-416.75%-31.18M
Cash flow from investment activities
Interest received - investment 82.27%17.98M----614.27%9.86M----774.05%1.38M----62.89%158K-----10.19%97K----
Sale of fixed assets 646.83%141.93M------19M----------------------2.14M----
Purchase of fixed assets 51.13%-339.6M----9.39%-694.88M-----877.66%-766.93M-----404.15%-78.45M-----19.66%-15.56M----
Sale of subsidiaries -109.84%-1.9M----118.70%19.35M-----72.99%8.85M----6,154.53%32.76M-------541K----
Recovery of cash from investments ------------------8.7M--------------------
Cash on investment ---5.27M---------------7K-------------105.02%-123.08M----
Other items in the investment business ----153.89%337.37M---530K-261.65%-625.98M-----36,187.63%-173.09M----96.53%-477K----58.32%-13.76M
Net cash from investment operations 71.13%-186.86M153.89%337.37M13.48%-647.2M-261.65%-625.98M-1,542.82%-748.01M-36,187.63%-173.09M66.75%-45.53M96.53%-477K-70.68%-136.95M58.32%-13.76M
Net cash before financing 109.37%97.9M590.85%512.86M40.31%-1.04B86.65%-104.48M-1,444.65%-1.75B-862.06%-782.67M31.31%-113.28M328.58%102.7M-415.45%-164.92M-93.97%-44.93M
Cash flow from financing activities
New borrowing 30.28%3.7B----147.75%2.84B----24.38%1.15B----529.82%922.01M------146.39M----
Refund -111.25%-3.45B-----727.02%-1.63B----7.10%-197.52M-----423.23%-212.6M-------40.63M----
Interest paid - financing -29.54%-66.56M-----103.99%-51.39M-----356.75%-25.19M-----61.59%-5.52M-----4,390.79%-3.41M----
Absorb investment income 91.13%61.93M------32.4M----------------------1.26M----
Other items of the financing business --4K-219.50%-658.81M-----6.64%551.29M--385M668.33%590.51M-----404.28%-103.9M289.94%57.81M234.65%34.15M
Net cash from financing operations -104.02%-47.69M-219.50%-658.81M-9.24%1.19B-6.64%551.29M86.30%1.31B668.33%590.51M338.66%701.95M-404.28%-103.9M615.83%160.02M234.65%34.15M
Effect of rate 158.08%8.11M154.36%9.06M59.64%-13.97M58.03%-16.66M-38.16%-34.6M-1,048.41%-39.69M-1,749.87%-25.05M751.87%4.19M-34.37%1.52M-688.99%-642K
Net Cash -64.75%50.22M-132.66%-145.94M132.23%142.48M332.53%446.81M-175.09%-442.02M-15,912.75%-192.15M12,108.73%588.67M88.87%-1.2M92.22%-4.9M77.78%-10.78M
Begining period cash 93.55%265.89M-50.99%265.89M-77.63%137.37M-11.64%542.53M1,118.90%614M1,118.90%614M-6.29%50.37M-6.29%50.37M-53.04%53.76M-53.04%53.76M
Cash at the end 21.94%324.22M-86.74%129M93.55%265.89M154.53%972.68M-77.63%137.37M616.20%382.15M1,118.90%614M26.05%53.36M-6.29%50.37M-35.91%42.33M
Cash balance analysis
Cash and bank balance -------------------------------------35.91%42.33M
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More